Real-World Outcome of Rheumatoid Arthritis Patients in Korea on Adalimumab

Rheumatoid Arthritis Satisfaction Outcome Research

NCT03703817 ·Status: COMPLETED

A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia

NCT01387789 ·Status: COMPLETED

Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

NCT01346488 ·Status: COMPLETED

Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis

NCT03011281 ·Status: UNKNOWN

Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World

NCT03264703 ·Status: COMPLETED

A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)

NCT00732875 ·Status: COMPLETED ·Phase: PHASE3

An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy

NCT01592292 ·Status: COMPLETED

Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.

NCT01835613 ·Status: UNKNOWN ·Phase: PHASE4

A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

NCT01464021 ·Status: TERMINATED

An Observational Quality of Life Study in Participants With Rheumatoid Arthritis Treated With Rituximab

NCT02507752 ·Status: COMPLETED

A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT00409838 ·Status: COMPLETED ·Phase: PHASE3

Quality of Life Study With Adalimumab in Rheumatoid Arthritis

NCT00234936 ·Status: COMPLETED ·Phase: PHASE3

A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA

NCT03147248 ·Status: COMPLETED ·Phase: PHASE3

Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)

NCT01382160 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01211834 ·Status: COMPLETED ·Phase: PHASE3

Prospective Cohort Study on Refractory Rheumatoid Arthritis

NCT07126431 ·Status: RECRUITING

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT01565122 ·Status: COMPLETED

Objective Study in Rheumatoid Arthritis

NCT00451971 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate

NCT01224418 ·Status: COMPLETED ·Phase: PHASE4

Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab

NCT01282372 ·Status: COMPLETED

A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

NCT00661284 ·Status: COMPLETED

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

NCT00649545 ·Status: APPROVED_FOR_MARKETING

Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.

NCT00195702 ·Status: COMPLETED ·Phase: PHASE3

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01543503 ·Status: COMPLETED

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01670045 ·Status: COMPLETED